Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Sonny7on Jan 26, 2020 10:51pm
89 Views
Post# 30601213

RE:in-eligible One ;) Think Harder Please ;)

RE:in-eligible One ;) Think Harder Please ;)wallyworld says he has me on ignore but I’ll respond to his babble just to be a good sport.    :)

He says his take is that it’s done for a reason, “a company strategy” ..... a clear cut case of rose colored glasses syndrome if there ever was one. Can anyone see a strategy?

Then the delusional one says: “Waiting and hoping for something decent on the FDA Trial soon(ish?). ..... has he expired all the good news that three subjects, according to him, were implanted? Is that accurate? ...word on the street (selphie street) is that the first trial subject was given a second dose of islets and there is no signs of insulin independence yet. So, a third dose is required according to selphie street rumours,  BUT, that doesn’t fit the FDA application and more time is needed for an amendment to be make to the trial submission to correct the original application in order to apply the addition of more pancreatic islets to search for the goal of insulin independence. Oh, Good! More Wait Time!! 

Do do we all agree that some form of explanation is in order from the company to shareholders? Do any agree that these questions are valid? Can anyone agree that rae selphie fabrications have expired themselves and there is absolutely ZERO credibility to be found anywhere near that jackass? Does anyone understand why the useless peckerwood is still being paid by US, the common simple supportive shareholder? Is there anoyone happy enough to die of old age and will their stock portfolio to grandchildren before they see the Sernova science and technology come to fruition? Will jwall ever think like an adult again? Will red buffoon ever be able to see past the end of his nose?

food for thought
Bullboard Posts